toward resolution and tissue repair. It also advances extracellular vesicle-based therapies and EV-loaded delivery systems as candidates for advanced wound care, including non-healing chronic wounds. Its research integrates immunology, regenerative biology, and nanomedicine to design targeted, locally delivered treatments that restore tissue homeostasis. EVolution Therapeutics operates at the preclinical stage, translating academic research into therapeutic candidates and delivery technologies for intractable inflammatory conditions.